Feature Channels:

Biotech

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cystic Fibrosis, Bacterial Infections, Antibiotic Resistance, Combination Therapy

Combination Therapy Provides Hope for Cure of Dangerous Infections of Cystic Fibrosis Patients

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

Medicine

Channels:

AAT deficiency, Cell Therapy, Regenerative Medicine

Liver-Cell Transplants Show Promise In Reversing Genetic Disease Affecting Liver and Lungs

Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation. Jayanta Roy-Chowdhury, M.D., professor of medicine and of genetics at Albert Einstein College of Medicine of Yeshiva University, is the study’s senior author.

Science

Channels:

Yeast, Immunocompromised

Simple Fungus Reveals Clue to Immune System Protection

A discovery by Johns Hopkins scientists about how a single-celled fungus survives in low-oxygen settings may someday help humans whose immune systems are compromised by organ transplants or AIDS.

Medicine

Channels:

Psoriais, goeckerman therapy, Biologics, Dermatology

With Buzz Over Biological Drugs, Psoriasis Patients Can Still Benefit from Long-established Treatments

U-M doctors stress a balanced approach, but note older therapies can offset risks, costs of ‘biologics’.

Medicine

Channels:

Cancer, Tumor, tubulin tyrosine ligase, TTL, Enzyme, carboxypeptidase, Tubulin, Microtubules, Cell Division

Taking Aim at Tumors: Novel Way of Studying Cancer may Inspire New Treatments

20100804_galbane08_jwc.jpg

Many of the newest weapons in the war on cancer come in the form of personalized therapies that can target specific changes in an individual’s tumor. By disrupting molecular processes in tumor cells, these drugs can keep the tumor from growing and spreading. At the forefront of this work are Binghamton University researchers, Susan Bane, and Susannah Gal, who are deploying a new tool in their study of an enzyme called tubulin tyrosine ligase, or TTL.

Science

Channels:

Makoto Kuro-o, Klotho, renal fibrosis, Chronic Kidney Disease, Cancer, Kidney Cancer

Anti-Aging Hormone Klotho Inhibits Renal Fibrosis, Cancer Growth

Kuro-oBoothman.jpg

A natural hormone known to inhibit aging can also protect kidneys against renal fibrosis, UT Southwestern Medical Center researchers have demonstrated.

Science

Channels:

Perimeter Institute, Leroy Hood, Systems Biology, Human Genome Project, Biotechnology, Dna Sequencing

Biotech Pioneer to Give Upcoming PI Public Lecture

On Wednesday, May 4, as part of Perimeter Institute’s Public Lecture Series presented by Sun Life Financial, Dr. Leroy Hood, a pioneer in systems approaches to biology and medicine, will discuss emerging technologies that may transform medical research over the next decade.

Medicine

Channels:

Encouraged by Early Clinical Studies, A Biotech Company Expands Its HIV/AIDS Vaccine Program

GOVX-HarrietRobinsonSM.jpg

The HIV Vaccine Trials Network plans to clinically test a novel vaccine product developed by GeoVax scientists that expresses human granulocyte-macrophage colony stimulating factor (GM-CSF) in combination with inactivated HIV proteins.

Science

Channels:

Escherichia Coli, E. Coli, E. Coli Bacteria, Commensal Bacteria, fecal coliform test, fecal pollution, environmental bacteria, environmental e. coli, Genome Sequencing, Taxonomy

Study Provides New Means for Classifying E. coli Bacteria & Testing for Fecal Contamination

kostas_R035_hires.jpg

The meaning of the standard fecal coliform test used to monitor water quality has been called into question by a new study that identified sources of Escherichia coli bacteria that might not indicate an environmental hazard.

Medicine

Channels:

IPF, Pulmonary Fibrosis, bosentan, clinical trial, interstitial lung disease, ILD

IPF Drug Fails in New Trial

A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis (IPF).







Chat now!